Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,731.60
(
1.56%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.21
(
-0.46%
)
Bitcoin
79,797.87
(
0.65%
)
News Focus
News Focus
Post# of 447919
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Chromosome

Send PM Follow Ignore
Followers 6
Posts 388
Boards Moderated 0
Alias Born 02/09/2022

Chromosome

Re: Number sleven post# 430589

Sunday, 11/17/2024 5:05:09 PM

Sunday, November 17, 2024 5:05:09 PM

Post# of 447919
Tirzepitide is known under the brand name Mounjaro Dual GLP agonist with better glycemic control and more weight loss than Ozempic which is a single GLP agonist. Weight loss indication is I believe for BMI higher than 30. My understanding is it is indicated for HF and being studied in other CV. It’s not for everyone and I feel that Vascepa has its place and doesn’t need a huge market share to be successful.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News